PRECIPIO, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
PRECIPIO, INC. (PRPO) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2016-11-14
- PRECIPIO, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2016-03-31 was 0.00%.
- PRECIPIO, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2015-03-31 was 0.00%.
- PRECIPIO, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2014-09-30 was 0.00%.
- PRECIPIO, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2014-06-30 was 0.00%.
- PRECIPIO, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2012 was 0.00%.
- PRECIPIO, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2011 was 0.00%.
- PRECIPIO, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2010 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|
| 2016-09-30 | 0.00% 10-Q · filed 2016-11-14 | |||
| 2016-06-30 | 0.00% 10-Q · filed 2016-08-15 | |||
| 2016-03-31 | 0.00% 10-Q · filed 2016-05-23 | |||
| 2015-09-30 | 0.00% 10-Q · filed 2015-11-16 | |||
| 2015-06-30 | 0.00% 10-Q · filed 2015-08-14 | |||
| 2015-03-31 | 0.00% 10-Q · filed 2015-05-14 | |||
| 2014-09-30 | 0.00% 10-Q · filed 2014-11-12 | |||
| 2014-06-30 | 0.00% 10-Q · filed 2014-08-08 | |||
| 2014-03-31 | 0.00% 10-Q · filed 2014-05-15 | |||
| 2013-09-30 | 0.00% 10-Q · filed 2013-11-14 | |||
| 2013-06-30 | 0.00% 10-Q · filed 2013-08-08 | |||
| 2013-03-31 | 0.00% 10-Q · filed 2014-05-15 | |||
| 2012-12-31 | 0.00% 10-K · filed 2013-03-14 | |||
| 2012-09-30 | 0.00% 10-Q · filed 2013-11-14 | 0.00% 10-Q · filed 2012-11-08 | ||
| 2012-06-30 | 0.00% 10-Q · filed 2013-08-08 | 0.00% 10-Q · filed 2012-08-02 | ||
| 2012-03-31 | 0.00% 10-Q · filed 2013-05-09 | |||
| 2011-12-31 | 0.00% 10-K · filed 2013-03-14 | |||
| 2011-06-30 | 0.00% 10-Q · filed 2012-08-02 | |||
| 2010-12-31 | 0.00% 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |